Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Surface Oncology Inc
About SURF
Surface Oncology, Inc. is a clinical-stage, immuno-oncology company, which is focused on developing immunotherapies that target the tumor microenvironment. The Company is developing multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable an immunologic response and enhance outcomes for patients with cancer. The Company’s pipeline includes two wholly owned clinical-stage programs targeting IL-27 (SRF388) and SRF114 a preclinical program focused on depleting tumor regulatory T cells through targeting CCR8. In addition, the Company has two partnerships with pharmaceutical companies, including a collaboration with Novartis targeting CD73 (NZV930; Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (GSK4381562). The Company’s novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response and may be used alone or in combination with other therapies.
Find out what a historical investment in Surface Oncology Inc would be worth today using our SURF stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy SURF shares in Australia?
Buying SURF shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Surface Oncology Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SURF
What is the ticker symbol of Surface Oncology Inc?
The ticker symbol for Surface Oncology Inc is SURF.
How much is one share of SURF?
One share of SURF is valued at $0.95 as of 16 May 2026.
What is the market capitalisation of Surface Oncology Inc SURF?
As of 16 May 2026 Surface Oncology Inc has a market cap of -.
What is the 52-week high for Surface Oncology Inc stock?
The Surface Oncology Inc 52-week high stock price is $NaN.
What is the 52-week low for Surface Oncology Inc stock?
The Surface Oncology Inc 52-week low stock price is $NaN.
Can I buy SURF shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SURF shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SURF on Stake
- Buy SURF from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of SURF from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
SURF related stocks